Navigation Links
Pulmonary & Allergy Update highlights insights and advances
Date:2/6/2013

KEYSTONE, CO Feb. 6, 2013 - Nationally recognized faculty from National Jewish Health will discuss insights and recent advances in pulmonary medicine, asthma, allergies and immunology at the 35th Annual Pulmonary & Allergy Update at Keystone, Feb. 6-9. Topics will range from nutrition and asthma to the allergic impact of global warming, allergies to joint replacements and new dietary recommendations for food allergy.

Below are short summaries of several presentations. Download the complete agenda at http://www.nationaljewish.org/ProEd/Keystone Agenda 2013 FINAL.pdf. For more information, contact William Allstetter at allstetterw@njhealth.org or 303.398.1002.

Explaining the Asthma Epidemic: You Are What You Eat. (4 p.m., Feb. 6) Rand Sutherland, MD, MPH, will discuss emerging evidence on the role of nutrition in asthma, including recent findings on folate, vitamin D, Tylenol and obesity.

The Allergic Impact of Global Warming. (7 a.m., Feb 8) Richard Weber, MD, will discuss evidence that a warming globe has already lengthened the allergy season and increased pollen levels, two trends that are likely to continue.

Update on Food Allergy. (7:40 a.m., Feb 8) David Fleischer, MD, will discuss new recommendations for timing the introduction of potentially allergenic foods into infants' diets, as well as immunotherapy to desensitize food-allergic patients, and a new epinephrine injector.

Allergy to Metal and Cement in Joint Replacement. (7:40 a.m., Feb 9) Karin Pacheco, MD, MSPH, discusses allergies to metal and cement that can cause failure of prosthetic hips and knees, as well as new tests to detect the most common metal allergy nickel.

Is Asthma an Infectious Disease? (7:40 a.m. Feb. 7) Richard Martin, MD, will discuss the role of bacterial and viral infections in asthma and their relation to the "hygiene hypothesis" t
'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Vitamin C improves pulmonary function in newborns of pregnant smoking women
2. Pittsburgh Cardiologist Named Physician of the Year by Pulmonary Hypertension Association
3. A hands-on approach to treating patients with pulmonary disease
4. Joint EACPR and AHA statement empowers health care professional to use Clinical Cardiopulmonary Exercise Testing
5. Study shows breath analysis could help diagnose pulmonary nodules
6. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or a Heart Attack to Call the Johnson Law Group Now-Before Time Runs Out
7. US Drug Watchdog Now Urges Yaz Yasmin Birth Control Pill Users Who Suffered a Pulmonary Embolism or Other Serious Medical Issues to Call the Johnson Law Group-ASAP
8. Mount Sinai launches clinical trial to treat chronic pulmonary sarcoidosis
9. Research shows efficacy of treatment model developed at Women & Infants
10. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
11. Vendors in Nevada, Michigan, & Illinois to be Featured on the PartyPOP.com Online Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014 “Dr. Luciana Show – Aging and ... Dr. Luciana, is finding it challenging to stay on top ... care of hundreds of students, so the editing of the ... is completed, and she recently entered it into the festival ... of her husband, actor/screenwriter Gregory Graham , the aging ...
(Date:8/22/2014)... (ESMO), the leading pan-European organisation representing medical oncology ... individuals receiving the Society,s esteemed annual awards. The ... Joensuu and Peter Boyle on the occasion of ... , Carsten Bokemeyer will receive the ESMO Award ... cancer discovery into real benefit at patient level. ...
(Date:8/22/2014)... fainting. Each year approx. 265,000 Danes are acutely admitted ... research from Aarhus University and Aarhus University Hospital now ... every fourth patient are sent home again without ... to the acute hospitalisation., "Naturally, there is no need ... disprove that there is a serious illness. So some ...
(Date:8/22/2014)... Alzheimer,s disease can be slowed and some of ... is found in pomegranate. Also, the painful ... and Parkinson,s disease could be reduced, according to ... University of Huddersfield scientist Dr Olumayokun Olajide, who ... , Now, a new phase of research can ...
(Date:8/22/2014)... for the cancer Hodgkin lymphoma will be able to ... estimated their risk of premature menopause with different treatments. ... of the National Cancer Institute , are based on ... England and Wales treated for the cancer over a ... has suggested that women with Hodgkin lymphoma who receive ...
Breaking Medicine News(10 mins):Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Many patients are discharged without a diagnosis 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2Health News:Scientists map risk of premature menopause after cancer treatment 2
... Nationally recognized asbestos ... written. , ... (PRWEB) April 15, 2010 -- Although most asbestos use was banned in the early 1980s, ... household and building products, says Joseph W. Belluck, a New York attorney who represents clients ...
... Traditional ... distributor. , ... April 15, 2010 -- Arsa Imports of El Paso, Texas, distributor of ... in Mexican culture, demonstrate that their most innovative items requested by today,s market, from ...
... study in the April 15 issue of the ... a sleep disturbance is associated with clinically meaningful reductions ... this effect varies by race and sleep disorder. ... African-Americans who snored frequently, had insomnia symptoms or reported ...
... is showing promise for the treatment of men with ... multicenter study has concluded that the targeted therapy MDV3100 ... cancer (CRPC), known for its poor prognosis and limited ... Sloan-Kettering Cancer Center, appears early online and in an ...
... ... comprehensive and successful anti-obesity program, First Lady Michelle Obama’s “Let’s Move” campaign must ... , ... (Vocus) April 14, 2010 -- To be a truly comprehensive and successful ...
... ... relief. , ... 2010 -- Spring is in full bloom and many Americans are beginning to experience the ... America, an estimated 50 million Americans have allergies, so for many the arrival of spring ...
Cached Medicine News:Health News:Asbestos Exposure Continues to Scar U.S. Workers and Their Families, New York Attorney Says 2Health News:Asbestos Exposure Continues to Scar U.S. Workers and Their Families, New York Attorney Says 3Health News:Arsa Offers High Quality Supplements, Cosmetics and Magic Scents from Mexico for Less Than $10 2Health News:The association between sleep disturbances and reduced quality of life varies by race 2Health News:The association between sleep disturbances and reduced quality of life varies by race 3Health News:New targeted therapy effective in treating advanced prostate cancer 2Health News:New targeted therapy effective in treating advanced prostate cancer 3Health News:Childhood Obesity Interventions Must Begin Early, UCSF Experts Say 2Health News:Childhood Obesity Interventions Must Begin Early, UCSF Experts Say 3Health News:Childhood Obesity Interventions Must Begin Early, UCSF Experts Say 4Health News:Spring is a Headache for Allergy Sufferers 2Health News:Spring is a Headache for Allergy Sufferers 3
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, is pleased ... international medical cannabis conference taking place at the ... , on October 22, 2014.  The multilingual ... such as researchers, health professionals, and patients, to ...
(Date:8/22/2014)...  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the ... common stock and warrants at a price of $10,000 ... to deducting underwriting discounts and commissions and offering expenses ... immediately separable and will be issued separately.  The shares ... The NASDAQ Stock Market under the ticker symbol "WGBS" ...
(Date:8/21/2014)... Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... cancers and women,s health, has appointed Holly B. ... Markets. Ms. Bauzon has a proven track ... coverage for laboratory services companies. She has more than ... Inc., where she held the position of Director, Lab ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... from a Phase 1/2 study of perifosine in combination ... from or refractory to bortezomib , ... Biopharmaceuticals, Inc. (Nasdaq: KERX ) today announced ... combination with bortezomib (+/- dexamethasone) in patients with relapsed/refractory ...
... SOUTH SAN FRANCISCO, Calif., Dec. 9 Portola,Pharmaceuticals, ... advances in cardiovascular disease, inflammatory disease,and cancer, today ... a large Phase II clinical trial of PRT060128, ... undergoing non-urgent,percutaneous coronary intervention (PCI). , ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology 7Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 2Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: